NCT05414409View on ClinicalTrials.gov

The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action

PHASE2RecruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

November 2, 2026

Study Completion Date

November 2, 2026

Conditions
Type 1 DiabetesObesity
Interventions
DRUG

Metformin

Metformin is an oral medication that improves insulin sensitivity.

Trial Locations (1)

46202

RECRUITING

Indiana University School of Medicine, Indianapolis

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Heba M. Ismail

OTHER